|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| Exploration and evaluation expenses | |||||
| General and administrative expenses | |||||
| Operating loss | |||||
| Other items | |||||
| Nauru and Tonga warrant costs | |||||
| Change in fair value of royalty liability | |||||
| Equity-accounted investment loss | |||||
| Gain on dilution of investment | |||||
| Loss on termination of contract | |||||
| Change in fair value of warrant liability | |||||
| Foreign exchange loss (gain) | |||||
| Interest income | |||||
| Fees and interest on borrowings and credit facilities | |||||
| Loss and comprehensive loss for the year, before tax | |||||
| Tax Expense | |||||
| Loss and comprehensive loss for the year | |||||
| Loss per share - Basic (in dollars per share) | |||||
| Loss per share - Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding - basic | |||||
| Weighted average number of common shares outstanding - diluted |
Loading...
